haloperidol has been researched along with Narcolepsy in 4 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Narcolepsy: A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Withdrawal of the narcolepsy treatment and initiation of haloperidol 1 mg/day (the only antipsychotic treatment she could tolerate) improved the delusions, hallucinations and dysphoria but worsened the narcolepsy symptoms." | 3.85 | Narcolepsy-cataplexy and psychosis: a case study. ( Arango-Lopez, C; Canellas-Dols, F; Delgado, C; Peraita-Adrados, R, 2017) |
| "The persistent auditory hallucinations were correlated with rapid eye movement sleep symptoms during her disease process so that we concluded that her persistent auditory hallucinations and delusion of observation were due to narcoleptic symptoms." | 1.31 | A narcoleptic patient exhibiting hallucinations and delusion. ( Maeda, H; Mukai, M; Sakamoto, T; Satomura, T; Takeuchi, N; Uchimura, N, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canellas-Dols, F | 1 |
| Delgado, C | 1 |
| Arango-Lopez, C | 1 |
| Peraita-Adrados, R | 1 |
| Schrader, G | 1 |
| Hicks, EP | 1 |
| Takeuchi, N | 1 |
| Mukai, M | 1 |
| Uchimura, N | 1 |
| Satomura, T | 1 |
| Sakamoto, T | 1 |
| Maeda, H | 1 |
| Gilbert, JC | 1 |
| Willer, JC | 1 |
| Bernheim-Chatelain, C | 1 |
| Ecoffet, M | 1 |
| Jaillon, P | 1 |
4 other studies available for haloperidol and Narcolepsy
| Article | Year |
|---|---|
Narcolepsy-cataplexy and psychosis: a case study.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compound | 2017 |
Narcolepsy, paranoid psychosis, major depression, and tardive dyskinesia.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder; Dextroamphetamine; Dyskinesi | 1984 |
A narcoleptic patient exhibiting hallucinations and delusion.
Topics: Delusions; Diagnosis, Differential; Female; Hallucinations; Haloperidol; Humans; Middle Aged; Narcol | 2000 |
[Letter: Narcolepsy. Suppression of paradoxical sleep by L-dopa].
Topics: Catecholamines; Cyproterone; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levod | 1976 |